Increased gene delivery efficiency and specificity of a lipid-based nanosystem incorporating a glycolipid
Hepatocellular carcinoma (HCC) is the third most common cause of death related to cancer diseases worldwide. The current treatment options have many limitations and reduced success rates. In this regard, advances in gene therapy have shown promising results in novel therapeutic strategies. However,...
| Autor principal: | |
|---|---|
| Outros Autores: | , , |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2014
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10316/27575 |
| País: | Portugal |
| Oai: | oai:estudogeral.sib.uc.pt:10316/27575 |